Skip to main content


Latest articles

17-03-2021 | Rheumatology | News | Article

Interventions may be needed to encourage physical activity in patients with early RA

A significant proportion of patients with rheumatoid arthritis are not doing any physical activity when starting methotrexate treatment or stop soon after, researchers report.

16-03-2021 | Rheumatology | News | Article

AMARA: Adding rituximab to leflunomide may improve some outcomes for RA patients

Add-on rituximab treatment may improve some clinical outcomes for patients with rheumatoid arthritis and an inadequate response to leflunomide, suggest findings from the AMARA trial.

15-03-2021 | Rheumatology | News | Article

Secukinumab alternatives suggested for ankylosing spondylitis patients with pre-existing IBD

Researchers report that secukinumab is associated with an increased risk for gastrointestinal-related adverse events in patients with ankylosing spondylitis and pre-existing inflammatory bowel disease and say that prescribing alternatives should be considered.

12-03-2021 | Rheumatology | News | Article

iBEAT-OA trial: Digitally delivered exercise intervention beneficial for knee osteoarthritis

People with knee osteoarthritis taking part in an internet-based exercise program experience significant improvements in pain and function compared with those given usual care, suggest findings from a randomized controlled trial published in JAMA Network Open.

11-03-2021 | Rheumatology | News | Article

FDA approves tocilizumab for SSc-ILD

Click through for more information on this US approval

10-03-2021 | Rheumatology | News | Article

Depression, anxiety may decrease chances of sustained MDA in psoriatic arthritis

Depression and anxiety are linked to a decreased likelihood of achieving sustained minimal disease activity in people with psoriatic arthritis, Canadian researchers report.

09-03-2021 | Rheumatology | News | Article

Trial suggests no benefit of sarilumab for COVID-19

Treatment with the IL-6 receptor inhibitor sarilumab does not improve clinical outcomes for people with severe or critical COVID-19, trial results suggest.

08-03-2021 | Rheumatology | News | Article

COVINTOC: Routine use of tocilizumab not supported for COVID-19

The addition of tocilizumab to standard care does not reduce the risk for disease progression among hospitalized patients with moderate-to-severe COVID-19, suggest findings from the COVINTOC trial conducted in India.

05-03-2021 | Rheumatology | News | Article

High rates of long-term glucocorticoid use in people with GCA, PMR

Real-world study results suggest that less than a third of patients with giant cell arteritis and/or polymyalgia rheumatica are able to discontinue glucocorticoid treatment for at least 6 months, and a substantial proportion remain on prednisone for at least 2 years.

04-03-2021 | Rheumatology | News | Article

Telephone CBT for insomnia possible option for patients with osteoarthritis

Cognitive behavioral therapy for insomnia could be delivered via the telephone to patients with osteoarthritis, proving useful for those unable to access in-person options, OATS trial findings suggest.

03-03-2021 | Rheumatology | News | Article

Secondary CVD prevention ‘should be priority’ after myocardial infarction in RA patients

Following myocardial infarction, people with rheumatoid arthritis have an elevated long-term risk for mortality and further cardiovascular disease events, researchers report.

02-03-2021 | Rheumatology | News | Article

Fibromyalgia-related pain not improved with vitamin D supplementation

Twelve weeks of high-dose vitamin D supplementation does not improve pain levels for women with fibromyalgia, research suggests.

01-03-2021 | Rheumatology | News | Article

Study highlights risk for disordered eating in adolescents with chronic musculoskeletal pain

Researchers have found that adolescents with chronic musculoskeletal pain, particularly those with gastrointestinal problems, may be at risk for disordered eating.

26-02-2021 | Rheumatology | News | Article

REMAP-CAP, COVACTA trials show mixed results for IL-6 blockade in COVID-19

Findings from the REMAP-CAP trial indicate that add-on treatment with tocilizumab or sarilumab may be beneficial for critically ill patients with COVID-19, whereas COVACTA suggests comparable outcomes with tocilizumab versus placebo in those with severe COVID-19 pneumonia.

25-02-2021 | Rheumatology | News | Article

PsA linked to heightened risk for type 2 diabetes

People with psoriatic arthritis may have an elevated risk for type 2 diabetes that is mediated in part by BMI, researchers report.

24-02-2021 | Rheumatology | News | Article

Rheumatologists have ‘crucial role’ in increasing COVID-19 vaccine uptake

Two studies have evaluated the perspectives of people with rheumatic and musculoskeletal diseases on COVID-19 vaccination, with both finding that a physician’s recommendation would improve patients’ willingness to be vaccinated.

23-02-2021 | Rheumatology | News | Article

Real-world data show tocilizumab effectiveness for GCA

Real-world data confirm the effectiveness of tocilizumab for decreasing relapse risk and allowing corticosteroid reduction in heavily treated patients with giant cell arteritis.

22-02-2021 | Rheumatology | News | Article

No benefit of apremilast for patients with ankylosing spondylitis

The phase 3 POSTURE trial has demonstrated no clinical benefit of apremilast for patients with active ankylosing spondylitis and no prior exposure to biologic agents.

19-02-2021 | Rheumatology | News | Article

Treatment response unaffected by diagnosis age in older people with RA

Older people with late-onset rheumatoid arthritis show a similar response to biologic or targeted synthetic DMARDs to their peers whose disease onset was earlier in life, Japanese study findings indicate.

18-02-2021 | Rheumatology | News | Article

START trial shows no benefit of high-intensity strength training for knee osteoarthritis

High-intensity strength training does not significantly reduce pain or knee joint compressive forces among people with knee osteoarthritis, suggest findings from the START trial.

Image Credits